Status:
COMPLETED
Effect of Two Different Fasting Blood Glucose Targets on Glucose Control in Patients With Type 2 Diabetes Using Insulin Detemir Once Daily
Lead Sponsor:
Novo Nordisk A/S
Conditions:
Diabetes
Diabetes Mellitus, Type 2
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
This trial is conducted in the United States of America. The aim of this trial is to explore how different fasting blood glucose targets affect glucose control in patients with type 2 diabetes, when p...
Eligibility Criteria
Inclusion
- Type 2 diabetes
- 1-3 oral treatments
- Insulin naive
- BMI (Body Mass Index) less than or equal to 45
Exclusion
- Pregnancy
- Retinopathy
- Cardiac disease
- Uncontrolled hypertension
- Recurrent hypoglycaemia
Key Trial Info
Start Date :
February 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2008
Estimated Enrollment :
244 Patients enrolled
Trial Details
Trial ID
NCT00634842
Start Date
February 1 2008
End Date
October 1 2008
Last Update
March 10 2017
Active Locations (69)
Enter a location and click search to find clinical trials sorted by distance.
1
Novo Nordisk Investigational Site
Goodyear, Arizona, United States, 85395
2
Novo Nordisk Investigational Site
Scottsdale, Arizona, United States, 85251-5638
3
Novo Nordisk Investigational Site
Searcy, Arkansas, United States, 72143
4
Novo Nordisk Investigational Site
Artesia, California, United States, 90701